Scinai Immunotherapeutics Ltd Adr has split its stock 3 times since its initial public offering (IPO). The first stock split occurred on November 25, 2022 with the ratio of 1-for-10, meaning that for 10 shares of SCNI owned pre-split, shareholders then owned 1 share. 2 more splits have been implemented since then. The most recent stock split took place on August 21, 2026 on a 1-for-10 basis.
These splits have increased SCNI stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Scinai Immunotherapeutics Ltd Adr's total market capitalization.
For more detailed information of Scinai Immunotherapeutics Ltd Adr's stock splits, view the table below:
The answer will depend on the decisions of the company's managers and market volatility. Scinai Immunotherapeutics Ltd Adr has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when SCNI stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Scinai Immunotherapeutics Ltd Adr's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
